Highnoon Laboratories Ltd
Highnoon Laboratories Ltd operates in Pharmaceuticals.
Highnoon Laboratories Ltd (HINOON) - Net Assets
Latest net assets as of : PKRs- PKR
Based on the latest financial reports, Highnoon Laboratories Ltd (HINOON) has net assets worth PKRs- PKR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (PKRs-) and total liabilities (PKRs-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | PKRs- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Highnoon Laboratories Ltd - Net Assets Trend (None–None)
This chart illustrates how Highnoon Laboratories Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Highnoon Laboratories Ltd (None–None)
The table below shows the annual net assets of Highnoon Laboratories Ltd from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Highnoon Laboratories Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Highnoon Laboratories Ltd Competitors by Market Cap
The table below lists competitors of Highnoon Laboratories Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DLT Resolution Inc
PINK:DLTI
|
$28.82K |
|
TEMPLETON E.M.I.TR.LS-05
F:1NK0
|
$28.83K |
|
Ngenic AB
ST:NGENIC
|
$28.84K |
|
ORG
WAR:ORG
|
$28.86K |
|
Arab Pharmaceuticals
EGX:ADCI
|
$28.81K |
|
FUTBOL CLUBE PORT R
MU:FBC
|
$28.80K |
|
BRF SA
STU:P5Y
|
$28.77K |
|
AD PEPPER MEDIA
MU:APM
|
$28.76K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Highnoon Laboratories Ltd's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Highnoon Laboratories Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Highnoon Laboratories Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Highnoon Laboratories Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.
Industry Context
- Industry: Pharmaceuticals
- Average net assets among peers: $17,227,128,333
- Average return on equity (ROE) among peers: 15.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Highnoon Laboratories Ltd (HINOON) | PKRs- | N/A | N/A | $28.82K |
| Abbott Laboratories Pakistan Ltd (ABOT) | $13.24 Billion | 20.36% | 0.53x | $31.06K |
| AGP Ltd (AGP) | $12.36 Billion | 12.66% | 1.26x | $6.39K |
| The Searle Company Ltd (SEARL) | $26.09 Billion | 14.10% | 0.88x | $2.95K |